Patent US4279992A successfully refreshed from Google Patents.
US4279992A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Specific binding assay employing an enzyme-cleavable substrate as label
Assignee: Bayer Corp
•
Filing: 1979-10-23
•
Granted: 1981-07-21
•
Expires: 1999-10-23
Abstract
Abstract An improved specific binding assay method and reagent for determining a ligand in a liquid medium employing, as an enzyme-cleavable substrate label, a residue having the formula: G-D-R wherein G is a glycone, D is a dye indicator moiety, and R is a linking group through which the label residue is covalently bound to a binding component of a conventional binding assay system, such as the ligand, an analog thereof, or a specific binding partner thereof. The monitored characteristic of the label is the release of a detectable product, usually a fluorogen or chromogen, upon enzymatic cleavage of the glycosidic linkage between the glycone and the dye indicator moiety. The assay method may follow a homogeneous or heterogeneous format. The preferred glycone is a beta -galactosyl group and the preferred dye indicator moiety is an umbelliferone residue. The improved assay is particularly suited to the determination of haptens, such as drugs, and antigenic proteins and polypeptides, including antibodies, following a homogeneous competitive binding assay format.
Inventors
- 👤 Robert C. Boguslaski
- 👤 John F. Burd
- 👤 Robert J. Carrico
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-24 20:13
CPC Classifications
C; C07; C07D; C07D209/00; C07D209/02; C07D209/44; C07D209/48; C07D233/00; C07D233/54; C07D233/66; C07D233/72; C07D233/76; C07D233/78; C07H; C07H17/00; C07H17/04; C07H17/06; C07H17/065; C07H17/075; G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/53; G01N33/531; G01N33/532; G01N33/533; G01N33/535; Y; Y10; Y10S; Y10S435/00; Y10S435/81; Y10S435/961; Y10S436/00; Y10S436/80; Y10S436/815; Y10S436/816
Claims Analysis
Total Claims: 56
Claim 1
Independent Claim
188 words
In a homogeneous specific binding assay method for determining a ligand in a liquid medium, wherein a reaction mixture is formed by combining said liquid medium with reagent means, including a conjugate having a label component and a binding component, to form a binding reaction system having a bound-species and a free-species of said labeled conjugate, said label component of the conjugate comprising an enzyme substrate-active portion and an indicator portion whereby the conjugate is cleavable by an enzyme to produce a detectable indicator product, said labeled conjugate being substantially inactive as a substrate for said enzyme when in said bound-species, wherein said cleaving enzyme is added to said reaction mixture and the resulting indicator product measured as a function of the amount of said ligand in said liquid medium, the improvement which comprises employing as said label component of the conjugate, a residue having the formula: ##STR25## wherein R is a linking group through which said residue is covalently bound to said binding component, and employing β-galactosidase as said cleaving enzyme whereby the β-galactosyl group in said residue can be cleaved to release a detectable dye product.
Claim 2
Dependent Claim
188 words
In a homogeneous specific binding assay method for determining a ligand in a liquid medium, wherein a reaction mixture is formed by combining said liquid medium with reagent means, including a conjugate having a label component and a binding component, to form a binding reaction system having a bound-species and a free-species of said labeled conjugate, said label component of the conjugate comprising an enzyme substrate-active portion and an indicator portion whereby the conjugate is cleavable by an enzyme to produce a detectable indicator product, said labeled conjugate being substantially inactive as a substrate for said enzyme when in said bound-species, wherein said cleaving enzyme is added to said reaction mixture and the resulting indicator product measured as a function of the amount of said ligand in said liquid medium, the improvement which comprises employing as said label component of the conjugate, a residue having the formula: ##STR25## wherein R is a linking group through which said residue is covalently bound to said binding component, and employing β-galactosidase as said cleaving enzyme whereby the β-galactosyl group in said residue can be cleaved to release a detectable dye product.
Claim 3
Dependent Claim
16 words
The method of claim 1 wherein said detectable dye product is detected by its fluorescence properties.
Claim 4
Dependent Claim
17 words
The method of claim 1 wherein said ligand is a hapten or an antigenic protein or polypeptide.
Claim 5
Dependent Claim
18 words
The method of claim 1 wherein said ligand is a hapten of molecular weight between 100 and 1000.
Claim 6
Dependent Claim
11 words
The method of claim 4 wherein said hapten is a drug.
Claim 7
Dependent Claim
21 words
The method of claim 1 wherein said ligand is an antigenic protein or polypeptide of molecular weight between 1,000 and 10,000,000.
Claim 8
Dependent Claim
14 words
The method of claim 6 wherein said antigenic protein or polypeptide is an antibody.
Claim 9
Independent Claim
34 words
The method of any of claims 3-7 wherein said linking group is a bond or a chain containing 1 to 10 carbon atoms and 0 to 5 heteratoms selected from nitrogen, oxygen and sulfur.
Claim 10
Dependent Claim
181 words
In a homogeneous specific binding assay method for determining a ligand in a liquid medium, wherein said liquid medium is combined with (1) a labeled conjugate comprising said ligand or a binding analog thereof coupled to a label component, which label component comprises an enzyme substrate-active portion and an indicator portion whereby the labeled conjugate is cleavable by an enzyme to produce a detectable indicator product, (2) a specific binding partner of said ligand, said labeled conjugate being substantially inactive as a substrate for said enzyme when bound by said binding partner of said ligand, and (3) said cleaving enzyme, and wherein the resulting indicator product is measured as a function of the amount of said ligand in said liquid medium, the improvement which comprises employing as said label component of the conjugate, a residue having the formula: ##STR26## wherein R is a linking group through which said residue is covalently bound to said ligand or analog thereof, and employing β-galactosidase as said cleaving enzyme whereby the β-galactosyl group in said residue can be cleaved to release a detectable dye product.
Claim 11
Dependent Claim
181 words
In a homogeneous specific binding assay method for determining a ligand in a liquid medium, wherein said liquid medium is combined with (1) a labeled conjugate comprising said ligand or a binding analog thereof coupled to a label component, which label component comprises an enzyme substrate-active portion and an indicator portion whereby the labeled conjugate is cleavable by an enzyme to produce a detectable indicator product, (2) a specific binding partner of said ligand, said labeled conjugate being substantially inactive as a substrate for said enzyme when bound by said binding partner of said ligand, and (3) said cleaving enzyme, and wherein the resulting indicator product is measured as a function of the amount of said ligand in said liquid medium, the improvement which comprises employing as said label component of the conjugate, a residue having the formula: ##STR26## wherein R is a linking group through which said residue is covalently bound to said ligand or analog thereof, and employing β-galactosidase as said cleaving enzyme whereby the β-galactosyl group in said residue can be cleaved to release a detectable dye product.
Claim 12
Dependent Claim
16 words
The method of claim 9 wherein said detectable dye product is detected by its fluorescence properties.
Claim 13
Dependent Claim
17 words
The method of claim 9 wherein said ligand is a hapten or an antigenic protein or polypeptide.
Claim 14
Dependent Claim
18 words
The method of claim 9 wherein said ligand is a hapten of molecular weight between 100 and 1000.
Claim 15
Dependent Claim
11 words
The method of claim 12 wherein said hapten is a drug.
Claim 16
Dependent Claim
35 words
The method of claim 13 wherein said drug is an aminoglycoside antibiotic, diphenylhydantoin, phenobarbital, primidone, carbamazepine, ethosuximide, sodium valproate, theophylline, propranolol, quinidine, procainamide, amitriptyline, cortisol, cyclophosphamide, desipramine, disopyramide, doxepin, doxorubicin, imipramine, lidocaine, methotrexate, or nortriptyline.
Claim 17
Dependent Claim
21 words
The method of claim 9 wherein said ligand is an antigenic protein or polypeptide of molecular weight between 1,000 and 10,000,000.
Claim 18
Dependent Claim
14 words
The method of claim 15 wherein said antigenic protein or polypeptide is an antibody.
Claim 19
Dependent Claim
13 words
The method of claim 16 wherein said antibody is IgG, IgM or IgA.
Claim 20
Independent Claim
32 words
The method of claims 11-17 wherein said linking group is a bond or a chain containing 1 to 10 carbon atoms and 0 to 5 heteroatoms selected from nitrogen, oxygen and sulfur.
Claim 21
Dependent Claim
170 words
In a homogeneous specific binding assay method for determining a ligand in a liquid medium, wherein said liquid medium is combined with (1) a labeled conjugate comprising a specific binding partner of said ligand coupled to a label component, which label component comprises an enzyme substrate-active portion and an indicator portion whereby the labeled conjugate is cleavable by an enzyme to produce a detectable indicator product, said labeled conjugate being substantially inactive as a substrate for said enzyme when bound by said ligand, and (2) said cleaving enzyme, and wherein the resulting indicator product is measured as a function of the amount of said ligand in said liquid medium, the improvement which comprises employing as said label component of the conjugate, a residue having the formula: ##STR27## wherein R is a linking group through which said residue is covalently bound to said binding partner of said ligand and employing β-galactosidase as said cleaving enzyme whereby the β-galactosyl group in said residue can be cleaved to release a detectable dye product.
Claim 22
Dependent Claim
170 words
In a homogeneous specific binding assay method for determining a ligand in a liquid medium, wherein said liquid medium is combined with (1) a labeled conjugate comprising a specific binding partner of said ligand coupled to a label component, which label component comprises an enzyme substrate-active portion and an indicator portion whereby the labeled conjugate is cleavable by an enzyme to produce a detectable indicator product, said labeled conjugate being substantially inactive as a substrate for said enzyme when bound by said ligand, and (2) said cleaving enzyme, and wherein the resulting indicator product is measured as a function of the amount of said ligand in said liquid medium, the improvement which comprises employing as said label component of the conjugate, a residue having the formula: ##STR27## wherein R is a linking group through which said residue is covalently bound to said binding partner of said ligand and employing β-galactosidase as said cleaving enzyme whereby the β-galactosyl group in said residue can be cleaved to release a detectable dye product.
Claim 23
Dependent Claim
16 words
The method of claim 19 wherein said detectable dye product is detected by its fluorescence properties.
Claim 24
Dependent Claim
11 words
The method of claim 19 wherein said ligand is an antibody.
Claim 25
Dependent Claim
18 words
The method of claim 21 wherein said binding partner is a hapten or an antigenic protein or polypeptide.
Claim 26
Dependent Claim
19 words
The method of claim 21 wherein said binding partner is a hapten of molecular weight between 100 and 1000.
Claim 27
Dependent Claim
22 words
The method of claim 21 wherein said binding partner is an antigenic protein or polypeptide of molecular weight between 1,000 and 10,000,000.
Claim 28
Dependent Claim
17 words
The method of claim 23 or 24 wherein said ligand is an IgG, IgM, or IgA antibody.
Claim 29
Dependent Claim
32 words
The method of claim 21 wherein said linking group is a bond or a chain containing 1 to 10 carbon atoms and 0 to 5 heteroatoms selected from nitrogen, oxygen and sulfur.
Claim 30
Dependent Claim
113 words
In a reagent means for determining a ligand in a liquid medium, which means includes (1) a conjugate having a label component and a binding component, said label component comprising an enzyme substrate-active portion and an indicator portion, and (2) an enzyme capable of acting on said substrate-active portion to cleave said labeled conjugate to produce a detectable indicator product, the improvement wherein said label component of the conjugate is a residue having the formula ##STR28## wherein R is a linking group through which said residue is covalently bound to said binding component, and wherein β-galactosidase is said cleaving enzyme whereby the β-galactosyl group can be cleaved to release a detectable dye product.
Claim 31
Dependent Claim
113 words
In a reagent means for determining a ligand in a liquid medium, which means includes (1) a conjugate having a label component and a binding component, said label component comprising an enzyme substrate-active portion and an indicator portion, and (2) an enzyme capable of acting on said substrate-active portion to cleave said labeled conjugate to produce a detectable indicator product, the improvement wherein said label component of the conjugate is a residue having the formula ##STR28## wherein R is a linking group through which said residue is covalently bound to said binding component, and wherein β-galactosidase is said cleaving enzyme whereby the β-galactosyl group can be cleaved to release a detectable dye product.
Claim 32
Dependent Claim
18 words
The reagent means of claim 27 wherein said ligand is a hapten or an antigenic protein or polypeptide.
Claim 33
Dependent Claim
19 words
The reagent means of claim 27 wherein said ligand is a hapten of molecular weight between 100 and 1000.
Claim 34
Dependent Claim
12 words
The reagent means of claim 29 wherein said hapten is a drug.
Claim 35
Dependent Claim
22 words
The reagent means of claim 27 wherein said ligand is an antigenic protein or polypeptide of molecular weight between 1,000 and 10,000,000.
Claim 36
Dependent Claim
15 words
The reagent means of claim 31 wherein said antigenic protein or polypeptide is an antibody.
Claim 37
Dependent Claim
35 words
The reagent means of any of claims 28-32 wherein said linking group is a bond or a chain containing 1 to 10 carbon atoms and 0 to 5 heteroatoms selected from nitrogen, oxygen and sulfur.
Claim 38
Dependent Claim
154 words
In a reagent means for determining a ligand in a liquid medium by a homogeneous specific binding assay, which means includes (1) a labeled conjugate comprising said ligand or a binding analog thereof coupled to a label component, which label component comprises an enzyme substrate-active portion and an indicator portion whereby the labeled conjugate is cleavable by an enzyme to produce a detectable indicator product, (2) a specific binding partner of said ligand, said labeled conjugate being substantially inactive as a substrate for said enzyme when bound by said binding partner of said ligand, and (3) said cleaving enzyme, the improvement wherein said label component of the conjugate is a residue having the formula: ##STR29## wherein R is a linking group through which said residue is covalently bound to said ligand or analog thereof, and wherein β-galactosidase is said cleaving enzyme whereby said β-galactosyl group can be cleaved to release a detectable dye product.
Claim 39
Dependent Claim
154 words
In a reagent means for determining a ligand in a liquid medium by a homogeneous specific binding assay, which means includes (1) a labeled conjugate comprising said ligand or a binding analog thereof coupled to a label component, which label component comprises an enzyme substrate-active portion and an indicator portion whereby the labeled conjugate is cleavable by an enzyme to produce a detectable indicator product, (2) a specific binding partner of said ligand, said labeled conjugate being substantially inactive as a substrate for said enzyme when bound by said binding partner of said ligand, and (3) said cleaving enzyme, the improvement wherein said label component of the conjugate is a residue having the formula: ##STR29## wherein R is a linking group through which said residue is covalently bound to said ligand or analog thereof, and wherein β-galactosidase is said cleaving enzyme whereby said β-galactosyl group can be cleaved to release a detectable dye product.
Claim 40
Dependent Claim
18 words
The reagent means of claim 34 wherein said ligand is a hapten or an antigenic protein or polypeptide.
Claim 41
Dependent Claim
19 words
The reagent means of claim 34 wherein said ligand is a hapten of molecular weight between 100 and 1000.
Claim 42
Dependent Claim
12 words
The reagent means of claim 36 wherein said hapten is a drug.
Claim 43
Dependent Claim
36 words
The reagent means of claim 37 wherein said drug is an aminoglycoside antibiotic, diphenylhydantoin, phenobarbital, primidone, carbamazepine, ethosuximide, sodium valproate, theophylline, propranolol, quinidine, procainamide, amitriptyline, cortisol, cyclophosphamide, desipramine, disopyramide, doxepin, doxorubicin, imipramine, lidocaine, methotrexate, or nortriptyline.
Claim 44
Dependent Claim
22 words
The reagent means of claim 34 wherein said ligand is an antigenic protein or polypeptide of molecular weight between 1,000 and 10,000,000.
Claim 45
Dependent Claim
15 words
The reagent means of claim 39 wherein said antigenic protein or polypeptide is an antibody.
Claim 46
Dependent Claim
14 words
The reagent means of claim 40 wherein said antibody is IgG, IgM or IgA.
Claim 47
Dependent Claim
35 words
The reagent means of any of claims 35-41 wherein said linking group is a bond or a chain containing 1 to 10 carbon atoms and 0 to 5 hereroatoms selected from nitrogen, oxygen and sulfur.
Claim 48
Dependent Claim
143 words
In a reagent means for determining a ligand in a liquid medium by a homogeneous specific binding assay, which means includes (1) a labeled conjugate comprising a specific binding partner of said ligand coupled to a label component, which label component comprises an enzyme substrate-active portion and an indicator portion whereby the labeled conjugate is cleavable by an enzyme to produce a detectable indicator product, said labeled conjugate being substantially inactive as a substrate for said enzyme when bound by said ligand, and (2) said cleaving enzyme, the improvement wherein said label component of the conjugate is a residue having the formula: ##STR30## wherein R is a linking group through which said residue is covalently bound to said binding partner of said ligand and wherein β-galactosidase is said cleaving enzyme whereby the β-galactosyl group can be cleaved to release a detectable dye product.
Claim 49
Dependent Claim
143 words
In a reagent means for determining a ligand in a liquid medium by a homogeneous specific binding assay, which means includes (1) a labeled conjugate comprising a specific binding partner of said ligand coupled to a label component, which label component comprises an enzyme substrate-active portion and an indicator portion whereby the labeled conjugate is cleavable by an enzyme to produce a detectable indicator product, said labeled conjugate being substantially inactive as a substrate for said enzyme when bound by said ligand, and (2) said cleaving enzyme, the improvement wherein said label component of the conjugate is a residue having the formula: ##STR30## wherein R is a linking group through which said residue is covalently bound to said binding partner of said ligand and wherein β-galactosidase is said cleaving enzyme whereby the β-galactosyl group can be cleaved to release a detectable dye product.
Claim 50
Dependent Claim
12 words
The reagent means of claim 43 wherein said ligand is an antibody.
Claim 51
Dependent Claim
19 words
The reagent means of claim 49 wherein said binding partner is a hapten or an antigenic protein or polypeptide.
Claim 52
Dependent Claim
20 words
The reagent means of claim 44 wherein said binding partner is a hapten of molecular weight between 100 and 1000.
Claim 53
Dependent Claim
23 words
The reagent means of claim 44 wherein said binding partner is an antigenic protein or polypeptide of molecular weight between 1,000 and 10,000,000.
Claim 54
Dependent Claim
18 words
The reagent means of claim 46 or 47 wherein said ligand is an IgG, IgM or IgA antibody.
Claim 55
Dependent Claim
33 words
The reagent means of claim 44 wherein said linking group is a bond or a chain containing 1 to 10 carbon atoms and 0 to 5 heteroatoms selected from nitrogen, oxygen and sulfur.
Claim 56
Dependent Claim
18 words
The reagent means of any of claims 27, 34 and 43 in the form of a test kit.
References Cited (Backward Citations)
US4039385A
Cited
US3950322A
Cited
US4123614A
Cited
US3957584A
Cited
US4134792A
Cited
US4226978A
Cited
US4171432A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1984-07-20 | 1985-01-19 | 1985-07-21 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1988-07-20 | 1989-01-19 | 1989-07-21 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1992-07-20 | 1993-01-19 | 1993-07-21 | $7700.00 | Window Closed / Lapsed |